Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXp Power Regulatory News (XPP)

Share Price Information for Xp Power (XPP)

Share Price is delayed by 15 minutes
Get Live Data
1,784.00    -78.00 (-4.19%)
Bid:
1,776.00
Ask:
1,788.00
Spread: 12.00 (0.676%)
Market Cap: £500.09m
XPP Live PriceLast checked at - London Stock Exchange

Intraday Xp Power Share Chart

Trading Update

16 Feb 2024 07:00

XP Power Ltd - Trading Update

XP Power Ltd - Trading Update

PR Newswire

LONDON, United Kingdom, February 16

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO 596/2014 (AS IT FORMS PART OF RETAINED EU LAW AS DEFINED IN THE EUROPEAN UNION (WITHDRAWAL) ACT 2018).

FOR IMMEDIATE RELEASE.

16 February 2024

 

 

XP Power Limited

(`XP Power' or `the Group' or `the Company')

 

Trading update - initial view on 2024 outlook

 

XP Power, one of the world's leading developers and manufacturers of critical power control solutions for the Industrial Technology, Healthcare and Semiconductor Manufacturing Equipment sectors, provides an initial view of the outlook for the year ending 31 December 2024 ("2024" or "the year").

 

2024 outlook

The Board has concluded that there is likely to be a shortfall in revenue in 2024, leaving the outlook for 2024 significantly below market expectations. This is based on recent order intake, revenue performance and discussions with customers, particularly within the Healthcare and Industrial Technology sectors, which confirm unusual, temporarily soft demand conditions and destocking. These softer trends have also emerged within our direct industry peers.

In early 2024, we have seen, as expected, the continuation of the ongoing cyclical slowdown in the Semiconductor Manufacturing Equipment sector and we continue to expect conditions in this sector to improve as the year progresses.

We now expect to also see a slowdown in the Industrial Technology and Healthcare sales, driven particularly by customer inventory movements. These markets are not typically cyclical for us. The slowdown in 2024 is driven by customer stock movements as they reduce their inventory in response to shorter delivery lead times.

In general, we expect the weakness we are currently seeing to be relatively short lived and indeed there have been some more encouraging signals from certain customers, especially for 2025, in recent weeks. The timing and speed of the recovery is hard to predict however. We expect 2024 to be significantly second half weighted with an improvement in trading as the year progresses.

Cost savings

As outlined in January, the cost savings actions previously announced remain on track and the Group has identified additional savings that will be delivered in the first quarter. These combined actions will significantly lower overheads year-on-year while preserving capability to respond to the recovery when it comes.

Balance sheet

The Group's cash generation toward the end of 2023 was ahead of expectations, as reflected in the year-end net debt position of £112.7m, and we expect this to continue in 2024 with net debt below our prior assumption. A trading performance in line with the Board's expectations would leave net debt/EBITDA at 31 December 2024 at or below 2.5x versus a covenant limit of 3.5x. The Group maintains significant levels of liquidity.

2023 full year results

Our year-end financial close processes have identified some capitalised product development costs that needed to be amortised or impaired, adding £4 million to costs. This is a non-cash item. Approximately half of this is one-off in nature. Underlying operating profit for full year 2023 absent these costs was in line with our expectations.

The Group will announce its results for the year ended 31 December 2023 on 5 March 2024.

Medium term outlook

The Board remains confident that the Group has strong medium-term prospects, and significant value, underpinned by our leading market position and broad product portfolio.

 

Enquiries:

XP Power  

Gavin Griggs, Chief Executive Officer +44 (0)118 976 5155

Matt Webb, Chief Financial Officer  +44 (0)118 976 5155

 Citigate Dewe Rogerson 

Kevin Smith/Lucy Gibbs +44 (0)20 7638 9571

 

XP Power designs and manufactures power controllers, the essential hardware component in every piece of electrical equipment that converts power from the electricity grid into the right form for equipment to function. Power controllers are critical for optimal delivery in challenging environments but are a small part of the overall customer product cost.

XP Power typically designs power control solutions into the end products of major blue-chip OEMs, with a focus on the Semiconductor Manufacturing Equipment (circa 32% of sales), Industrial Technology (circa 43% of sales) and Healthcare (circa 25% sales) and sectors. Once designed into a programme, XP Power has a revenue annuity over the life cycle of the customer's product which is typically five to seven years depending on the industry sector.

 

XP Power has invested in research and development and its own manufacturing facilities in China, North America, and Vietnam, to develop a range of tailored products based on its own intellectual property that provide its customers with significantly improved functionality and efficiency.

 

Headquartered in Singapore and listed on the Main Market of the London Stock Exchange since 2000, XP Power is a constituent of the FTSE SmallCap Index. XP Power serves a global blue-chip customer base from over 30 locations in Europe, North America, and Asia.

 

For further information, please visit xppowerplc.com

 

 

 

 

 

 



Date   Source Headline
22nd May 202612:28 pmPRNHolding(s) in Company
7th May 20269:30 amPRNHolding(s) in Company
5th May 20264:09 pmPRNHolding(s) in Company
1st May 20269:27 amPRNGrant of LTIP and RSP awards
30th Apr 20266:00 pmRNSFTSE Russell Index Changes
30th Apr 202611:45 amPRNHolding(s) in Company
23rd Apr 202611:46 amRNSResult of AGM
23rd Apr 20267:00 amRNSQ1 Trading Update
31st Mar 20269:48 amPRNDirector/PDMR Shareholding
19th Mar 20262:52 pmPRNAnnual Financial Report
11th Mar 20269:44 amRNSGrant of LTIP, RSP and DBP awards
11th Mar 20269:44 amPRNGrant of LTIP, RSP and DBP awards
4th Mar 20264:12 pmRNSDirector/PDMR Shareholding
3rd Mar 20264:18 pmRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSAnnual Results for the year ended 31 December 2025
19th Jan 20267:00 amRNSFull Year Trading Update
7th Jan 20267:00 amPRNNotification of Q4 and Full Year 2025 Trading Update
16th Dec 20253:36 pmPRNDirector/PDMR Shareholding
12th Dec 20259:00 amPRNBlocklisting - Interim Review
8th Dec 202510:04 amPRNHolding(s) in Company
5th Dec 20257:03 amPRNBoard Changes
5th Nov 20257:00 amPRNInvestor Seminar
24th Oct 20251:08 pmPRNDirector/PDMR Shareholding
21st Oct 20257:00 amPRNQ3 Trading Update
13th Oct 20255:37 pmPRNHolding(s) in Company
3rd Oct 20257:01 amPRNNotice of Q3 2025 Trading Update & Investor Seminar
3rd Oct 20257:00 amPRNBoard Change
24th Sep 202510:21 amPRNHolding(s) in Company
1st Sep 20259:53 amPRNTotal Voting Rights
28th Aug 202511:02 amPRN2025 Annual General Meeting Voting Outcome Update
14th Aug 20252:56 pmPRNHolding(s) in Company
5th Aug 20257:00 amPRNInterim Results
12th Jun 20259:02 amPRNBlocklisting - Interim Review
2nd May 20254:59 pmPRNHolding(s) in Company
24th Apr 20251:53 pmPRNHolding(s) in Company
24th Apr 202511:49 amPRNResult of AGM
24th Apr 20257:00 amPRNQ1 Trading Update
22nd Apr 20254:57 pmPRNHolding(s) in Company
1st Apr 20259:34 amPRNTotal Voting Rights
20th Mar 20252:06 pmPRNAnnual Financial Report
12th Mar 20259:23 amPRNHolding(s) in Company
7th Mar 20254:53 pmPRNHolding(s) in Company - Correction
6th Mar 20253:40 pmPRNHolding(s) in Company
6th Mar 20253:38 pmPRNHolding(s) in Company
6th Mar 20253:34 pmPRNGrant of LTIP, RSP and DBP awards
5th Mar 20252:37 pmPRNHolding(s) in Company
4th Mar 20251:37 pmPRNResults of Retail Offer and Total Voting Rights
4th Mar 20259:49 amPRNResults of Placing and PDMR Shareholdings
4th Mar 20257:06 amPRNRetailBook Offer
4th Mar 20257:05 amPRNAnnouncement of Placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.